-
31.发明授权바실러스 아밀로리퀴페시언스(Bacillus amyloliquefaciens)에 의한 콩 발효물을 유효성분으로 포함하는 간 질환 예방, 개선 또는 치료용 조성물 有权解淀粉芽孢杆菌芽孢杆菌作为活性成分，用于预防改善或治疗包含发酵大豆物质的肝脏疾病的组合物
公开(公告)号：KR101635982B1
公开(公告)日：2016-07-07
申请号：KR1020140107609
申请日：2014-08-19
Applicant: 한국식품연구원
Abstract: 본발명은바실러스아밀로리퀴페시언스()에의한콩 발효물을유효성분으로포함하는간 질환(liver disorders) 예방, 개선또는치료용조성물에관한것이다. 본발명의바실러스아밀로리퀴페시언스에의한콩 발효물은α-SMA 발현억제활성을가짐으로써간 섬유화를억제할수 있어간 질환예방, 개선또는치료용조성물로사용이가능한이점이있다.
-
公开(公告)号：KR1020150046781A
公开(公告)日：2015-04-30
申请号：KR1020150052561
申请日：2015-04-14
Applicant: 한국식품연구원
Abstract: 본발명은청국장에탄올용해(ethanol-soluble) 추출물을유효성분으로포함하는전신면역및 장관면역보강제에관한것으로, 본발명의청국장에탄올용해(ethanol-soluble) 추출물을포함하는면역보강제는안전성이확보된식품소재를사용함으로써독성및 부작용이없으며, 저렴한생산비용과사용의편이성을제공할수 있다. 또한, 본발명의면역보강제는면역원과경구투여시 경구감염성병원성미생물은물론비경구감염성병원성미생물이나바이러스, 암항원, 일반항원등에대하여도 Th1 및 Th2 반응을유도하며효과적인특이항체 (혈중 IgG 및소장 IgA)를생산할수 있다.
Abstract translation: 本发明涉及一种全身或肠内免疫佐剂，其包含可溶于乙醇的Cheonggukjang（韩国快速发酵豆酱）提取物作为活性成分。 本发明的免疫佐剂既没有毒性也没有副作用，因为使用安全保证的食物，可以降低生产成本并提供易于使用。 此外，免疫佐剂以及免疫原的口服给药可通过诱导Th1和Th2对肠外感染性致病微生物以及口腔感染性致病微生物的应答产生有效的特异性抗体（血液中的IgG和小肠中的IgA） 或病毒，癌抗原，常见抗原等
-
33.发明公开바실러스 아리아바타이(Bacillus aryabhattai) 또는 바실러스 아리아바타이(Bacillus aryabhattai)에 의한 콩 발효물을 유효성분으로 포함하는 항알레르기성 조성물 有权含有BACILLUS ARYABHATTAI的抗过敏组合物或使用物种的发芽大豆的物质
公开(公告)号：KR1020140053677A
公开(公告)日：2014-05-08
申请号：KR1020120119898
申请日：2012-10-26
Applicant: 한국식품연구원
Abstract: The present invention relates to an anti-allergic composition which comprises Bacillus aryabhattai or a fermented soybean substance using Bacillus aryabhattai as an active ingredient. The Bacillus aryabhattai or the fermented soybean substance using Bacillus aryabhattai of the present invention is excellent for promoting Th1 cellular response and inhibiting Th2 cellular response, thereby can adjust balance of Th1/Th2 immune response.
Abstract translation: 本发明涉及一种抗过敏组合物，其包含芽孢杆菌属（Bacillus aryabhattai）或使用芽孢杆菌属（Bacillus aryabhattai）作为活性成分的发酵大豆物质。 使用本发明的芽孢杆菌的芽孢杆菌或发酵大豆物质对于促进Th1细胞应答和抑制Th2细胞应答是极好的，从而可以调节Th1 / Th2免疫应答的平衡。
-
34.发明公开바실러스 메틸로트로피쿠스(Bacillus methylotrophicus) 또는 바실러스 메틸로트로피쿠스(Bacillus methylotrophicus)에 의한 콩 발효물을 유효성분으로 포함하는 항알레르기성 조성물 有权含有BACILLUS METHYLOTROPHICUS的抗过敏组合物或使用物种的发芽大豆的物质
公开(公告)号：KR1020140053673A
公开(公告)日：2014-05-08
申请号：KR1020120119894
申请日：2012-10-26
Applicant: 한국식품연구원
Abstract: The present invention relates to an anti-allergic composition which comprises Bacillus methylotrophicus or a fermented soybean substance using Bacillus methylotrophicus as an active ingredient. The Bacillus methylotrophicus or the fermented soybean substance using Bacillus methylotrophicus of the present invention is excellent for promoting Th1 cellular response and inhibiting Th2 cellular response, thereby can adjust balance of Th1/Th2 cytokine.
Abstract translation: 本发明涉及一种抗过敏组合物，其包含甲硝酸芽孢杆菌或使用甲氨喋呤作为活性成分的发酵大豆物质。 使用本发明的甲氨喋呤的芽孢杆菌甲基营养生物或发酵大豆物质对于促进Th1细胞应答和抑制Th2细胞应答是极好的，从而可以调节Th1 / Th2细胞因子的平衡。
-
35.发明公开바실러스 메틸로트로피커스 ＴＰＰ 0025를 포함하는 항당뇨 효과가 증강된 콩발효물 有权含有BACILLUS METHYLOTROPHICUS TPP的含有大豆的抗大豆蛋白的增强功能及其方法
公开(公告)号：KR1020140050410A
公开(公告)日：2014-04-29
申请号：KR1020120116797
申请日：2012-10-19
Applicant: 한국식품연구원
CPC classification number: A23L11/00 , A23L33/135 , A23V2002/00 , A23V2200/328 , C12N1/20 , C12R1/07
Abstract: The present invention relates to a fermented soybean with an enhanced anti-diabetic effect and a method for manufacturing the same, and more specifically, to the method for manufacturing a fermented soybean with an enhanced anti-diabetic effect comprising the steps of: inoculating a multiplied soybean with a Bacillus genus strain; and fermenting the inoculated soybean with the strain, and the fermented soybean manufactured by the method. Provided in the present invention is the fermented soybean having an anti-diabetic activity by the strain having a high alpha-glucosidase inhibition activity.
Abstract translation: 本发明涉及具有增强的抗糖尿病作用的发酵大豆及其制造方法，更具体地说，涉及具有增强的抗糖尿病作用的发酵大豆的制造方法，包括以下步骤：接种繁殖 具有芽孢杆菌属菌株的大豆; 并用菌株发酵接种的大豆，以及通过该方法制造的发酵大豆。 本发明提供了具有高α-葡糖苷酶抑制活性的菌株具有抗糖尿病活性的发酵大豆。
-
Patent Agency Ranking36.发明公开바실러스 아밀로리쿼파시엔스 서브스페시스 플란타럼 Ｆ1275를 포함하는 항당뇨 효과가 증강된 콩발효물 및 이의 제조방법 有权含有BACILLUS AMYLOLIQUEFACIENS SUBSP的发酵大豆。 PLANTARUM F1275增强抗糖尿病的功能及其方法
公开(公告)号：KR1020140050409A
公开(公告)日：2014-04-29
申请号：KR1020120116795
申请日：2012-10-19
Applicant: 한국식품연구원
CPC classification number: A23L11/00 , A23L33/135 , A23V2002/00 , A23V2200/328 , C12N1/20 , C12R1/07
Abstract: The present invention relates to a fermented soybean with an enhanced anti-diabetic effect and a method for manufacturing the same, and more specifically, to the method for manufacturing a fermented soybean with an enhanced anti-diabetic effect comprising the steps of: inoculating a multiplied soybean with a Bacillus genus strain; and fermenting the inoculated soybean with the strain, and the fermented soybean manufactured by the method. Provided in the present invention is the fermented soybean having an anti-diabetic activity by the strain having a high alpha-glucosidase inhibition activity.
Abstract translation: 本发明涉及具有增强的抗糖尿病作用的发酵大豆及其制造方法，更具体地说，涉及具有增强的抗糖尿病作用的发酵大豆的制造方法，包括以下步骤：接种繁殖 具有芽孢杆菌属菌株的大豆; 并用菌株发酵接种的大豆，以及通过该方法制造的发酵大豆。 本发明提供了具有高α-葡糖苷酶抑制活性的菌株具有抗糖尿病活性的发酵大豆。
-
公开(公告)号：KR1020140048488A
公开(公告)日：2014-04-24
申请号：KR1020120114421
申请日：2012-10-15
Applicant: 한국식품연구원
Abstract: The present invention relates to a Lactobacillus brevis 877G (KCCM11283P) strain producing gamma-amino butyric acid. By using the Lactobacillus brevis 877G (KCCM11283P) strain of the present invention, a user can produce GABA in high efficiency compared to existing production methods.
Abstract translation: 本发明涉及产生γ-氨基丁酸的短乳杆菌短乳杆菌877G（KCCM11283P）菌株。 通过使用本发明的短乳杆菌877G（KCCM11283P）菌株，与现有的生产方法相比，用户可以高效率地生产GABA。
-
38.发明公开1-데옥시노지리마이신을 생산하는 바실러스 아밀로리쿼파시엔스 26Ｎ 및 이를 이용한 항당뇨 활성이 있는 콩발효물의 제조방법 有权生产1-脱氧吉米奇的巴斯夫乳酸菌26N及其制备具有抗糖尿病活性的发酵大豆的方法
公开(公告)号：KR1020140047993A
公开(公告)日：2014-04-23
申请号：KR1020120114437
申请日：2012-10-15
Applicant: 한국식품연구원
IPC: C12N1/20 , C12P19/26 , A61K31/445 , C07D211/46
Abstract: The present invention can provide a bacillus amyloliquefaciens 26N strain producing 1-deoxynojirimycin (DNJ) and produce a functional food comprising 1-deoxynojirimycin and having antidiabetic, anticancer, and antiviral effects by using the same.
Abstract translation: 本发明可以提供产生1-脱氧野尻霉素（DNJ）的解淀粉芽孢杆菌26N菌株，并且通过使用它们产生包含1-脱氧野尻霉素并具有抗糖尿病，抗癌和抗病毒作用的功能性食品。
-
39.发明公开1-데옥시노지리마이신을 생산하는 바실러스 아밀로리쿼파시엔스 335Ｎ 및 이를 이용한 항당뇨 활성이 있는 콩발효물의 제조방법 有权制造1-脱氧吉米奇的巴西利亚氨基酸335N及其制备具有抗糖尿病活性的发酵大豆的方法
公开(公告)号：KR1020140047992A
公开(公告)日：2014-04-23
申请号：KR1020120114435
申请日：2012-10-15
Applicant: 한국식품연구원
IPC: C12N1/20 , C12P19/26 , A61K31/445 , C07D211/46
Abstract: The present invention enables users to produce a Bacillus amyloliquefaciens 335N (KCCM11285P) strain producing 1-deoxynojirimycin (DNJ); and a functional food having antidiabetic, anticancer, and antiviral effects containing the 1-deoxynojirimycin using the same.
Abstract translation: 本发明使用户能够生产产生1-脱氧野尻霉素（DNJ）的解淀粉芽孢杆菌335N（KCCM11285P）菌株; 以及含有使用其的1-脱氧野尻霉素的抗糖尿病，抗癌和抗病毒作用的功能性食品。
-
40.发明公开1-데옥시노지리마이신을 생산하는 바실러스 아밀로리쿼파시엔스 140Ｎ 및 이를 이용한 항당뇨 활성이 있는 콩발효물의 제조방법 有权生产1-脱氧吉米霉素的巴西利亚霉素140N及其制备具有抗糖尿病活性的发酵大豆的方法
公开(公告)号：KR1020140047982A
公开(公告)日：2014-04-23
申请号：KR1020120114423
申请日：2012-10-15
Applicant: 한국식품연구원
IPC: C12N1/20 , C12P19/26 , A61K31/445 , C07D211/46
Abstract: The present invention can provide a bacillus amyloliquefaciens 140N strain producing 1-deoxynojirimycin (DNJ), and produce soybean-fermented products comprising 1-deoxynojirimycin having anti-diabetic, anti-cancer, and anti-virus effects using the same.
Abstract translation: 本发明可以提供一种产生1-脱氧野尻霉素（DNJ）的解淀粉芽孢杆菌140N菌株，并且使用该芽孢杆菌产生具有抗糖尿病，抗癌和抗病毒作用的1-脱氧野尻霉素的大豆发酵产物。
-
-
-
-
-
-
-
-
-
Search Results
141
records
(took 0.028 seconds)
